| Oct 14 |
Best Momentum Stocks to Buy for October 14th
|
| Oct 10 |
DiaMedica gets SAHPRA approval for Phase II preeclampsia treatment trial
|
| Oct 9 |
DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia
|
| Sep 4 |
DiaMedica Therapeutics Upcoming Conference Participation
|
| Sep 3 |
Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?
|
| Aug 11 |
DiaMedica Therapeutics Inc. (DMAC) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year?
|
| Aug 1 |
DiaMedica Therapeutics to Provide a Business Update and Report Second Quarter 2024 Financial Results August 8, 2024
|
| Jul 11 |
DiaMedica: Early 2025 Interim Futility Analysis Could Be A Major Inflection Point
|
| Jul 11 |
DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 50% ownership, insiders own 39%
|
